Explore a selection of our essential drug information below, or:
Identification
- Summary
Urtica dioica pollen is an extract from Urtica dioica pollen used in allergy testing.
- Generic Name
- Urtica dioica pollen
- DrugBank Accession Number
- DB10763
- Background
Urtica dioica pollen is the pollen of the Urtica dioica plant. Urtica dioica pollen is mainly used in allergenic testing.
- Type
- Biotech
- Groups
- Approved
- Biologic Classification
- Allergenics
Allergen Extract - Synonyms
- nettle pollen extract
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.- Brand Name Prescription Products
Name Dosage Strength Route Labeller Marketing Start Marketing End Region Image Nettle Injection, solution 0.1 g/1mL Intradermal; Subcutaneous Nelco Laboratories, Inc. 1972-08-29 Not applicable US 
Nettle Injection, solution 20000 [PNU]/1mL Intradermal; Subcutaneous Nelco Laboratories, Inc. 1972-08-29 Not applicable US Nettle Injection, solution 20000 [PNU]/1mL Intradermal; Subcutaneous Nelco Laboratories, Inc. 1972-08-29 Not applicable US Nettle Injection, solution 10000 [PNU]/1mL Intradermal; Subcutaneous Nelco Laboratories, Inc. 1972-08-29 Not applicable US Nettle Solution 0.05 g/1mL Intradermal; Percutaneous; Subcutaneous Greer Laboratories, Inc. 1981-09-15 Not applicable US - Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image ANKAFERD DERİ ÇÖZELTİSİ İÇEREN AMPUL Urtica dioica pollen (6 g/100mL) + Alpinia officinarum leaf (7 g/100mL) + Glycyrrhiza glabra (7 g/100mL) + Grape seed oil (8 g/100mL) + Thyme (5 g/100mL) Solution Topical İMMÜN GIDA İLAÇ KOZMETİK SAN. VE TİC. LTD. ŞTİ. 2017-11-07 Not applicable Turkey 
PROSTAGOOD PLUS KAPSÜL, 120 ADET Urtica dioica pollen (120 mg) + Saw palmetto (160 mg) Capsule Oral ABDİ İBRAHİM İLAÇ SAN. VE TİC. A.Ş. 2006-03-22 Not applicable Turkey PROSTAGOOD PLUS KAPSÜL, 60 ADET Urtica dioica pollen (120 mg) + Saw palmetto (160 mg) Capsule Oral ABDİ İBRAHİM İLAÇ SAN. VE TİC. A.Ş. 2006-03-22 Not applicable Turkey Treamtent Set TS347738 Urtica dioica pollen (0.002 g/1mL) + Alternaria alternata (0.002 g/1mL) + Amaranthus retroflexus pollen (0.002 g/1mL) + Ambrosia artemisiifolia pollen (4000 [AU]/1mL) + Carya illinoinensis pollen (0.001 g/1mL) + Carya tomentosa pollen (0.001 g/1mL) + Cochliobolus sativus (0.00008 g/1mL) + Cynodon dactylon pollen (80 [BAU]/1mL) + Felis catus hair (400 [BAU]/1mL) + Fraxinus americana pollen (0.002 g/1mL) + Juglans nigra pollen (0.002 g/1mL) + Morus rubra pollen (0.002 g/1mL) + Pascopyrum smithii pollen (0.002 g/1mL) + Phleum pratense pollen (160 [BAU]/1mL) + Platanus occidentalis pollen (0.002 g/1mL) + Populus alba pollen (0.001 g/1mL) + Populus deltoides pollen (0.002 g/1mL) + Populus nigra pollen (0.001 g/1mL) + Quercus alba pollen (0.002 g/1mL) Injection, solution Intradermal; Subcutaneous Antigen Laboratories, Inc. 1986-10-31 Not applicable US Treatment Set TS129085 Urtica dioica pollen (0.002 g/1mL) + Acer rubrum pollen (0.0004 g/1mL) + Alternaria alternata (0.0004 g/1mL) + Amaranthus retroflexus pollen (0.0004 g/1mL) + Ambrosia artemisiifolia pollen (800 [AU]/1mL) + Carya tomentosa pollen (0.002 g/1mL) + Cladosporium cladosporioides (0.002 g/1mL) + Cynodon dactylon pollen (80 [BAU]/1mL) + Dermatophagoides farinae (120 [AU]/1mL) + Dermatophagoides pteronyssinus (120 [AU]/1mL) + Morus rubra pollen (0.002 g/1mL) + Mucor racemosus (0.002 g/1mL) + Plantago lanceolata pollen (0.0004 g/1mL) + Platanus occidentalis pollen (0.0004 g/1mL) + Pleospora herbarum (0.002 g/1mL) + Poa pratensis pollen (32 [BAU]/1mL) + Quercus alba pollen (0.0004 g/1mL) + Rumex acetosella pollen (0.0004 g/1mL) + Salsola kali pollen (0.0004 g/1mL) + Sorghum halepense pollen (0.00008 g/1mL) + Ulmus americana pollen (0.0004 g/1mL) Injection, solution Intradermal; Subcutaneous Antigen Laboratories, Inc. 1986-10-31 Not applicable US
Categories
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- DNB59M1NVU
- CAS number
- Not Available
References
Clinical Trials
- Clinical Trials
Clinical Trial & Rare Diseases Add-on Data Package
Explore 4,000+ rare diseases, orphan drugs & condition pairs, clinical trial why stopped data, & more. Preview package Phase Status Purpose Conditions Count Start Date Why Stopped 100+ additional columns Unlock 175K+ rows when you subscribe.View sample data
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Solution Topical Injection, solution Intradermal; Subcutaneous 0.05 g/1mL Injection, solution Intradermal; Subcutaneous 0.1 g/1mL Injection, solution Intradermal; Subcutaneous 10000 [PNU]/1mL Injection, solution Intradermal; Subcutaneous 20000 [PNU]/1mL Injection, solution Intradermal; Subcutaneous 40000 [PNU]/1mL Injection, solution Percutaneous 0.05 g/1mL Solution Intradermal; Percutaneous; Subcutaneous 0.001 g/1mL Solution Intradermal; Percutaneous; Subcutaneous 0.025 g/1mL Solution Intradermal; Percutaneous; Subcutaneous 0.05 g/1mL Solution Intradermal; Percutaneous; Subcutaneous 20000 [PNU]/1mL Injection Cutaneous; Intradermal; Subcutaneous 0.05 g/1mL Injection, solution Percutaneous; Subcutaneous 1 g/20mL Injection, solution Percutaneous; Subcutaneous 0.05 g/1mL Injection, solution Percutaneous; Subcutaneous 0.1 g/1mL Capsule Oral Injection, solution Intradermal; Subcutaneous - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
Drug created at December 01, 2015 20:04 / Updated at June 12, 2020 16:53